VEGFA and Hyperglycemia: The current study revealed that Glab treatment could alleviative hyperglycemia, IR, and renal dysfunction in vivo, and repress oxidative stress, ferroptosis, as well as the VEGF/Akt/ERK pathways both in vivo and in vitro.